Prednisone Dosing for Acute Spastic Cough: 3-Day Course
For an adult with acute spasmodic cough requiring a 3-day prednisone course, prescribe 30-40 mg orally once daily in the morning for 3 days, but only after ruling out common treatable causes like asthma, upper airway cough syndrome, and gastroesophageal reflux disease. 1, 2
Clinical Context and Evidence Base
The term "acute spastic cough" most closely aligns with postinfectious cough in the medical literature—a paroxysmal cough following respiratory infection. The ACCP guidelines specifically address this scenario and provide the clearest dosing recommendation.
When to Consider Corticosteroids
Postinfectious cough is defined as cough persisting 3-8 weeks after an acute respiratory infection 1. For severe paroxysms that significantly impair quality of life:
- First-line therapy: Inhaled ipratropium bromide (may attenuate cough) 1, 2
- Second-line: Inhaled corticosteroids if ipratropium fails 1
- For severe paroxysms: Oral prednisone 30-40 mg daily for a short, finite period 1, 2
Critical Exclusions Before Prescribing
You must rule out these common causes first 1:
- Upper airway cough syndrome (UACS) from rhinosinus disease
- Asthma or bronchial hyperresponsiveness
- Gastroesophageal reflux disease
- Bacterial sinusitis
- Early Bordetella pertussis infection
Failure to exclude these conditions is a common pitfall—corticosteroids may temporarily mask symptoms while the underlying condition progresses.
Specific Dosing Recommendations
For Postinfectious Cough (Most Relevant)
- Dose: 30-40 mg prednisone orally once daily 1, 2
- Duration: Short, finite period (3 days is reasonable for acute management)
- Timing: Morning administration preferred 3
- Evidence level: Low quality evidence, intermediate benefit, Grade C recommendation 1
Alternative Context: If This Were Asthma-Related
If the spastic cough were actually undiagnosed asthma or bronchospasm (which should be considered):
- Outpatient burst: 40-60 mg daily in single or 2 divided doses for 5-10 days 4, 5
- No taper needed for courses <1 week 4, 5
Important Caveats and Pitfalls
Evidence Limitations
The evidence for oral corticosteroids in acute cough is weak and conflicting:
- A 2017 RCT found no benefit of prednisolone for acute lower respiratory tract infection in adults without asthma (median cough duration 5 days in both groups) 6
- The 2020 CHEST guidelines suggest against routine use of oral corticosteroids for acute bronchitis 7
- However, the ACCP guidelines support use specifically for severe paroxysmal postinfectious cough when other causes are excluded 1, 2
When NOT to Prescribe
Do not use corticosteroids for 7, 6:
- Uncomplicated acute bronchitis
- Acute cough <3 weeks duration
- When diagnosis is uncertain
- Without first trying inhaled ipratropium 1
Administration Details
- Take with food to reduce gastric irritation 3
- Morning dosing (before 9 AM) minimizes HPA axis suppression 3
- No taper needed for 3-day course 4, 5
- Consider antacids if using higher doses 3
Practical Algorithm
- Confirm duration: Cough present 3-8 weeks post-respiratory infection
- Assess severity: Severe paroxysms affecting quality of life
- Rule out: UACS, asthma, GERD, bacterial sinusitis, pertussis
- First trial: Inhaled ipratropium bromide
- If inadequate response: Prednisone 30-40 mg PO daily × 3 days
- Monitor: If no improvement, reconsider diagnosis
Key Takeaway
The 30-40 mg daily dose for 3 days is appropriate for severe postinfectious cough, but this represents expert opinion with low-quality evidence. The more robust evidence actually suggests oral corticosteroids provide minimal benefit for most acute respiratory cough syndromes. Use this approach judiciously, only after excluding treatable causes and considering safer alternatives like inhaled ipratropium first.